Aldeyra received an FDA CRL for reproxalap, necessitating an additional study for DED approval. Read why I continue to rate ...

JPMorgan lowered the firm’s price target on AbbVie (ABBV) to $200 from $210 and keeps an Overweight rating on the shares. While the ...

The trial enrolled adults with a median age of 65 years who had undergone extensive prior treatments; 75% had previously received AbbVie’s Venclexta (venetoclax), and 36% had tried three or more lines ...

In this article, we are going to take a look at where NIKE, Inc. (NYSE:NKE) stands against the other best stocks under $100. Wall Street experts believe that mid-cap stocks might be well-placed ...

Despite a decline in revenue and subscribers, Chegg Inc (CHGG) focuses on brand campaigns and product differentiation to counter AI-driven market shifts. We recently compiled a list of the 14 AI ...

President-elect Donald J. Trump may accelerate the timetable for a truce. Kyiv views guarantees against renewed aggression as crucial to any settlement. By Andrew E. Kramer Mike Huckabee and ...

Mom of 3 was brutally tortured before being set ablaze in Manipur: Autopsy A horrifying incident in Manipur's Jiribam district has left the community reeling after a 31-year-old mother of three ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

© 2024 American City Business Journals. All rights reserved. Use of and/or registration on any portion of this site constitutes acceptance of our User Agreement ...

Zoom stock hits 52-week high at $86.24 amid market rally Zoom Video Communications Inc. (NASDAQ:ZM) stock soared to a 52-week high of $86.24, reflecting a robust rally that has captivated investors.

Covering Netflix News Independently Since 2013. What’s on Netflix is not owned by or affiliated with Netflix or any of its partners in any capacity. The authors of this site also have no affiliation ...